1.
Verma M, Gupta S, Bhagat BR, Mahajan A, Kaur B. Comparison of intravenous hydralazine and intravenous labetalol in the management of severe hypertensive disorders of pregnancy: a tertiary care centre study. Int J Reprod Contracept Obstet Gynecol [Internet]. 2018 May 26 [cited 2025 Oct. 14];7(6):2251-6. Available from: https://www.ijrcog.org/index.php/ijrcog/article/view/4721